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Abstract
The vast landscapeof RNA-protein interactions at the heart of post-transcriptional regulation remains largely unexplored. Indeed
it is likely that, even in yeast, a substantial fraction of the regulatory RNA-binding proteins (RBPs) remain to be discovered.
Systematic experimental methods can play a key role in discovering these RBPs - most of the known yeast RBPs lack RNA-binding
domains that might enable this activity to be predicted. We describe here a proteome-wide approach to identify RNA-protein
interactions based on in vitro binding of RNA samples to yeast protein microarrays that represent over 80% of the yeast
proteome. We used this procedure to screen for novel RBPs and RNA-protein interactions. A complementary mass spectrometry
technique also identified proteins that associate withyeast mRNAs.Both the protein microarrayandmassspectrometry methods
successfully identify previously annotated RBPs, suggesting that other proteins identified in theseassays might be novel RBPs. Of
35 putative novel RBPs identified by either or both of these methods, 12, including 75% of the eight most highly-ranked
candidates, reproducibly associated with specific cellular RNAs. Surprisingly, most of the 12 newly discovered RBPs were
enzymes. Functional characteristics of the RNA targets of some of the novel RBPs suggest coordinated post-transcriptional
regulation of subunits of protein complexes and a possible link between mRNA trafficking and vesicle transport. Our results
suggest that many more RBPs still remain to be identified and provide a set of candidates for further investigation.
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Introduction
The dynamic processes of a living cell depend on the
coordinated temporal and spatial regulation of the many steps of
gene expression. Combinatorial binding and control of gene
transcription by specific transcription factors allows for individual
regulation of each gene and concerted regulation of large sets of
genes in physiological and developmental programs. While
transcription is a major control point of gene expression, a gene’s
transcript can also be subject to regulation at the levels of RNA
processing, transport, localization, translation, and degradation.
The correlation between mRNA transcript abundance and protein
abundance was only 0.5–0.6 in a survey of 80% of the yeast
genome, suggesting significant post-transcriptional regulation [1].
Similar conclusions have been drawn from a comparison of
changes in mRNA transcript abundance to changes in protein
abundance in response to a shift in growth media [2].
Recent work further corroborates the existence of extensive post-
transcriptional regulatory networks, with an ever-growing list of
specific RNA binding proteins (RBPs) that bind distinct sets of
mRNAs encoding proteins destined for similar subcellular locations
or withsimilar biological functions [3,4,5,6,7].Nevertheless, very little
is known about the specific pathways involved in the posttranscrip-
tional regulation of gene expression or their molecular components.
One important part of defining the system that regulates the
posttranscriptional fate of mRNAs in Saccharomyces cerevisiae is to
identify all the proteins that interact with these RNAs. Currently,
over 600 proteins in S. cerevisiae are thought to bind RNA (Table
S1) [8]. Though this list of ‘‘known’’ RBPs is long, comprising
more than 10% of the yeast proteome, some proteins not
annotated as RBPs reproducibly co-immunipurify with distinct
sets of RNAs in vivo [5]. Most of the yeast proteins annotated as
RBPs (Table S1) lack domains known to bind RNA, and some
RBPs have other known functions that give no hint of their
involvement in the post-transcriptional regulation of RNA. For
example, the metabolic enzyme aconitase catalyses the isomeriza-
tion of citrate to isocitrate, but the cytosolic version also functions
as an RNA binding protein, binding to iron regulatory elements in
target mRNAs to regulate their expression in response to iron
availability [9]; Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) binds directly to AU-rich sequences in specific RNAs
in humans and in S. cerevisiae [5,10]; and enolase mediates the
mitochondrial import of specific tRNAs as the enolase-preMSK1
[11]. These and other examples of a regulatory RNA-binding
activity in unexpected proteins highlight the need for systematic
experimental methods for discovering novel RBPs [12].
We describe two methods to search for novel RNA-protein
interactions. The main approach used protein microarrays
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to interrogate RNA-protein interactions in vitro on a genome-wide
scale. Protein microarrays have been previously used to identify
proteins that interact with a small viral RNA hairpin [13]. A
complementary method combined affinity purification with mass
spectrometry to identify proteins from a whole cell lysate that co-
purify with total poly(A) mRNA.
Results and Discussion
Protein microarrays detect specific mRNA-protein
interactions with high sensitivity and specificity
Our goal was to survey the majority of the yeast proteome for
specific RNA-binding activity. We purified more than 4,700 GST-
tagged proteins, representing .80% of the yeast proteome [14].
451 of these 4,700 proteins are known or predicted to associate
with RNA [8]. 75 of the purified proteins were picked at random
and their identity verified by Western blotting (data not shown).
There were several potential sources of variation associated with
the protein purification method that we used to prepare the
protein microarrays. Protein-to-protein variation in expression and
purification efficiency could result in differences in the amount of
protein printed per spot. In addition, since all the proteins were
purified from yeast cells, we cannot exclude the possibility that
interacting proteins co-purified with the tagged protein nominally
present at a spot. Also, difference in protein stability and variability
in efficiency and manner of immobilization on the nitrocellulose
microarray surface due to charge or size could affect the amount of
properly folded and oriented protein in each spot. We first tested
whether, despite these potential limitations, we could use the
arrays to identify known specific RNA-protein interactions.
As a positive control, we chose the well-characterized ASH1
mRNA, which encodes an inhibitor of mating-type switching in
yeast [15,16,17]. During cell division, the ASH1 mRNA is
localized in a She2-dependent manner via Myo4 to daughter cell
nuclei, and Khd1-binding to the ASH1 mRNA ensures that it is
not translated until properly localized ([18,19,20,21] and others).
A protein microarray was incubated with a mixture of fluores-
cently labeled in vitro transcribed ASH1 mRNA and poly(A)-
selected total mRNA from cells harvested at mid-log phase in YPD
(Figure 1A). A total of four replicates were performed, and the Cy3
and Cy5 dyes used to label the mRNA samples were reversed
between replicates.
We ranked proteins by normalized mean intensity of the fluorescent
signal representing ASH1 mRNA measured at the cognate spot in the
microarray. For 42 proteins, the fluorescent signal in at least one of four
replicate experiments was at least two standard deviations above the
mean for all spots. Fluorescence ratios for proteins with signal below
this threshold showed no rank correlation between dye swaps
(Spearman correlation coefficient=0.09). Nine of those 42 proteins
had signal consistently two or more standard deviations above the
mean regardless of the Cy-dye label (Spearman correlation coeffi-
cient=0.7, p-value=1610
214, Table 1). These nine proteins were not
notably deviant in charge or abundance when compared to the
proteins that did not pass the threshold. Five of those nine proteins
were known RNA-binding proteins (She2, Npl3, Rrp5, Khd1,
Scp160), four of which have previously been reported to bind the
ASH1 transcript (Npl3, She2, Khd1, Scp160) [5,15,19]. The remaining
four proteins (Ydl124w, Gcy1, Pcs60 and Mdh3) were enzymes not
previously described to interact with nucleic acids.
The greater the specificity with which a protein binds to ASH1
in preference to other mRNAs, the higher the ratio of the
fluorescent signal corresponding to the labeled ASH1 compared to
the signal representing total mRNA. She2 and Khd1 were the two
proteins that showed the highest ratio of signal representing ASH1
RNA to the signal representing total mRNA reference (Log2G/R
(mean-centered) for She2 was 3.4 in ASH1-Cy3 experiments and
5.7 in ASH1-Cy5 experiments; Log2G/R (mean-centered) for
Khd1 was 1.1 in ASH1-Cy3 experiments and 3.7 in ASH1-Cy5
experiments). The lower signal ratios for the remaining seven
proteins suggest that they may represent RNA-binding proteins
with broader specificity. Indeed, Scp160 and Npl3 appear to
Figure 1. Methods for identifying novel RNA-binding proteins. A. A schematic representation of the protein microarray method. Specific
mRNA of interest is synthesized in vitro, while polyA-selected mRNA is isolated from mid-log phase cells grown in YPD. The samples are labeled with
Cy-dyes, pooled together and bound to a protein microarray. In subsequent analyses, proteins interacting with total mRNA or preferentially with
individual mRNA are identified. B. Proteins associating with mRNAs immobilized on oligo-dT beads were isolated and identified using LC-MS/MS.
doi:10.1371/journal.pone.0012671.g001
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was among the RNAs least enriched by affinity purification of
Scp160 or Npl3 [5].
Among the five candidate ASH1-interacting proteins newly
identified in this study (Rrp5, Gcy1, Pcs60, Ydl124w and Mdh3),
Rrp5p is a known RBP and Mdh3p contains an NAD(P)-binding
Rossman fold, a domain that has been previously reported to bind
directly to RNA [10,22]. In contrast, the remaining three
(Ydl124w, Gcy1, and Pcs60) do not have identifiable RNA-
binding domains. DNA microarray analysis of RNAs enriched in
association with TAP-tagged Gcy1 and Pcs60 identified specific
RNAs associated with each of these proteins (FDR#0.01%), but
ASH1 mRNA was not among the targets of either Gcy1 or Pcs60
at a stringent FDR threshold (see section ‘‘The novel RBPs
confirmed by RIP-Chip…’’ for further discussion of targets of
Gcy1 and Pcs60), consistent with the protein microarray evidence
that both proteins are RBPs with broader specificity.
Mass spectrometry identifies vesicle trafficking proteins
associated with yeast mRNA
As a complementary approach we captured poly(A) RNA from
cell lysate using oligo(dT) beads, followed by mass spectrometry to
identify RNA-associated proteins (Figure 1B). As a control for
‘‘background’’, we analyzed a sample of unfractionated whole cell
lysate by LC-MS/MS, reasoning that proteins detected in this
sample would represent potential false positives in the actual
mRNA affinity experiment by virtue of being highly abundant. In
all cases we considered as significant only those proteins for which
two or more unique peptides were identified with a Scaffold
protein identification probability of .95% [23].
In each experiment (including the whole cell lysate control) we
identified between 83 and 88 proteins that met the above criteria.
The proteins identified in the control sample were strongly biased
towards abundant proteins (average percentile rank in protein
abundance=97%) [1]; ribosomal proteins (hypergeometric p-
value=9.3610
23), Hsp70-chaperones (hypergeometric p-value=
1.8610
26), and tRNA synthetases (hypergeometric p-value=
2.7610
28) were disproportionately represented in this group.
Although many of these highly abundant proteins may indeed
bind specifically to RNA, we chose not to investigate them further.
68 proteins identified in the mRNA-affinity sample were not
present in the control sample (Table S2). 22 of these 68 proteins
were already annotated as RBPs (hypergeometric p-value=
8.8610
27 relative to their representation among mRNAs ex-
pressed in these cells). The Gene Ontology (GO) functional
categories most significantly enriched among the 68 proteins were




25) and ‘‘mRNA P-
body assembly’’ (hypergeometric p-value=1.8610
23).
Unexpectedly, several proteins involved in vesicular transport
and secretion (Sec1, Sec16, Sec31, Sec26, Sec27, Ubp3, Gvp36,
and Lsp1) were among the 46 proteins identified in the mRNA-
affinity isolated samples, but not heretofore annotated as RBPs.
Sec3p is required for the proper localization of the ASH1 mRNA,
andASH1 co-fractionateswithERmicrosomesina Sec3-and She2-
dependent manner [24]. However, none of the eight vesicle and
membranetraffickingproteinsweidentifiedhavebeenimplicated in
RNA transport or localization. The Sec proteins found by our mass
spectrometry approach include components of COPI and COPII,
localize to different parts of the cell (early and late Golgi vesicles,
ER, bud neck, cell cortex), and are implicated in different stages of
vesicle formation and trafficking. Microarray analysis of RNAs
associated with Ubp3, a protease with a role in anterograde and
retrograde transport between the ER and the Golgi, showed specific
enrichment of mRNAs encoding membrane, bud, and cell wall
Table 1. Proteins interacting with ASH1 mRNA identified in replicate dye-swap protein microarray experiments.
Protein Description Function Avg Cy3
Avg
Rank Cy3 Avg Cy5
Avg
Rank Cy5 pI Abundance
She2 RBP that interacts with She3p; restricts
accumulation of certain proteins to the bud
mRNA binding 17.1 3 17.8 18 4.7 4,070
YDL124W NADPH-dependent alpha-keto amide reductase alpha-keto ester
reductase activity
11.9 5 14.6 22 6.1 4,030
Gcy1 Putative NADP(+) coupled glycerol dehydrogenase oxidoreductase
activity
8.9 8 19.6 17 8.2 NA
Npl3 RBP that promotes elongation, regulates
termination, and carries poly(A) mRNA from
nucleus to cytoplasm; required for pre-mRNA
splicing
mRNA binding 7.1 12 153.8 1 5.4 78,700
Rrp5 RBP; preference for tracts of U’s; synthesis of
both 18S and 5.8S rRNAs
mRNA binding 3.8 20 14.6 23 6.1 8,860
Pcs60 AMP-binding protein; peroxisomal peripheral
membrane and matrix
ligase activity 3.7 21 89.8 4 10.0 8,770
Khd1 RBP that represses translation of ASH1 mRNA;
regulates telomere position effect and length
mRNA binding 3.4 24 24.0 15 6.0 15,600
Scp160 RBP; mating response pathway; nuclear
envelope and ER; interacts with translating
ribosomes
mRNA binding 2.9 29 117.7 3 5.7 NA
Mdh3 Peroxisomal malate dehydrogenase dehydrogenase
activity
2.9 31 60.2 8 10.0 3,300
These proteins had normalized mean signal over median background signal (for the ASH1 Cy-dye channel) equal to or greater than two SD above the mean for each
microarray experiment. Annotated RBPs are identified by bold text. ASH1mRNA microarray signal (Cy3 or Cy5) and rank are averaged over two replicates for each dye.
Protein abundance data are taken from [1], protein isoelectric point from [8].
doi:10.1371/journal.pone.0012671.t001
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These results suggest the possibility that the cell’s vesicular transport
system may play a more significant role in mRNA transport and
localization than previously recognized.
Although this method appears to have identified new RNA
binding proteins, it is subject to the limitations of conventional
mass spectrometry. In each run only ,85 proteins were identified
with high confidence, with a bias towards highly abundant
proteins (ribosomal proteins and chaperones). The protein
microarray approach therefore appears better suited for a
systematic interrogation of the RNA interaction propensity of
thousands of different yeast proteins in one rapid experiment.
Protein microarrays identify both known and unexpected
protein-mRNA interactions
To search for novel RNA-protein interactions, we probed
protein microarrays with fluorescently labeled yeast total mRNA.
The fluorescent intensity of a spot was used as a proxy for the
amount of mRNA bound and proteins were ranked by the ratio of
normalized mean signal intensity to median background (Table
S3). Results of dye swap control experiments correlated well
(Spearman correlation coefficient of fluorescence intensity values
between mRNA-Cy5 and mRNA-Cy3 experiments=0.7; data for
Cy3-mRNA experiments not shown).
We looked for evidence of artifactual signal variation attributable
to variable amount of protein per spot, protein size or charge. We
found no relationship between the fluorescent signal from each spot
and either the molecular weight (Figure S1 with data from [1]) or
the charge of the respective protein (Figure S2 with data from [8]),
suggesting that protein charge and size did not introduce a bias in
the efficiency of immobilization on the nitrocellulose microarray
surface or in the overall affinity of a protein for RNA. We used a
fluorescent anti-GST antibody to compare the amount of GST
tagged protein present in each spot and found that the relative
amount of GST-tagged protein present per spot did not correlate
with the amount of fluorescent mRNA bound (Pearson Correlation
Coefficient=20.023),suggesting that ourresults werenot biasedby
variation in the amount of protein per spot (Figure S3).
The fluorescent signal representing capture of mRNA was
systematically higher for known RBPs than for other proteins
(Wilcoxon test p-value=1.4610
210, Figure 2), suggesting that
other proteins with high fluorescent signal might represent novel
RBPs. To test this possibility, we used an independent experi-
mental method to identify which, if any cellular mRNAs might be
associated with a sample of the novel candidate RBPs.
Many of the candidate novel RBPs interact with specific
RNAs
We selected 35 proteins solely based on their ranks (ranging
from 3 to 3,746) in signal intensity in the protein microarray
experiments, irrespective of any known function or characteristics
of the proteins themselves (Table S4). The 35 sampled proteins
included enzymes, vesicle trafficking and intracellular transporters,
nucleic-acid binding proteins, actin related/associated proteins,
stress-response chaperones, chromatin remodeling components,
and methyltransferases. We analyzed each of them by affinity
isolation of the protein followed by microarray profiling of any
associated RNAs [25] using strains from the yeast TAP-tagged
collection. We included two known RBPs (Gus1 and Scd6) as
positive controls. Eight ‘‘Mock’’ IPs using lysates from isogenic
untagged strains were included as negative controls. We initially
performed one IP for each of the 35 candidate RBPs, followed by
an additional two replicates of the most promising candidates.
We used a normalization and background subtraction method,
described in Materials and Methods, to minimize the contribution
of nonspecific background, as modeled by the ‘‘Mock’’ enrichment
data. We used the Significance Analysis of Microarrays (SAM)
algorithm [26] to compare the replicate assays of each tested
protein to the Mock IP results. We considered sets of mRNAs that
had a False Discovery Rate (FDR) less than or equal to 0.01% as
estimated by the SAM algorithm; in the case of proteins with
greater than 500 mRNA targets according to these criteria, we also
required a Mock-Corrected Log2 Ratio value greater than 1 (see
‘‘Materials and Methods’’ for detailed explanation).
Based on this analysis, we found that the two ‘‘known RBP’’
positive controls (Gus1 and Scd6) and 12 (34%) of the 35 novel
candidates interacted reproducibly with specific sets of RNAs.
Some of the candidate RBPs (Lys1, Ubp3, Crg1, Arf3, Pcs60) co-
purified with many different, highly enriched transcripts, confirm-
ing that these proteins clearly interact with RNA. Other candidate
RBPs (Vtc1, Arc15, Hsp26, Arp8, Gis2) co-purified with smaller
sets of mRNAs, but these small sets of putative mRNA targets
shared distinct functional and/or cytotopical themes, increasing
our confidence that the RNA-protein interactions we observed
were genuine. Three of the candidate RBPs (Gcy1, Pad1, Bub1)
had fewer than 100 targets. Two additional proteins (Smy1, Mtq2)
had no targets at a stringent FDR threshold of 0.01%, though they
did have putative RNA targets at an FDR of ,1%. To empirically
test the false positive rate of our analysis procedure, we repeated
the analyses, treating randomly selected Mock IP data sets as if
they represented results for a candidate RBP (see ‘‘Materials and
Methods’’). In no case was a single mRNA identified as a target of
a ‘‘fake’’ RBP (at an FDR ,20%), further evidence that our
analysis methods are sufficiently stringent. Since Bub1 was
specifically associated only with its own mRNA transcript, we do
not count it as a bona fide RBP. To keep the criteria for identifying
Figure 2. Enrichment of annotated RBPs in the protein
microarray data. The red line represents proteins annotated as RBPs,
the blue line represents proteins not annotated as RBPs. Protein
microarrays were probed with 500 nM polyA-selected RNA labeled
with Cy5. Proteins were ranked by the ratio of normalized mean Cy5
signal to median microarray background. The Wilcoxon rank test was
used to evaluate the significance of enrichment of known RBPs relative
to proteins not annotated as RBPs.
doi:10.1371/journal.pone.0012671.g002
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in our tally of RBPs, but we report their putative targets for
informational purposes (Table S5).
A potential complication of any protein purification is contam-
ination with proteins that co-purify with the protein of interest.
When we analyzed the proteins that have been reported to co-
purify with the 12 candidate novel RBPs [27], we found that only
one has been reported to associate with a known RNA binding
protein: Ubp3 forms a complex with the RRM (RNA Recognition
Motif)-containing protein, Bre5. Since Ubp3 and Bre5 physically
interact to co-regulate the anterograde and retrograde transport
between the endoplasmic reticulum and Golgi compartments [28],
it is possible that Ubp3-Bre5 may also bind to RNA as a complex.
None of the other candidate novel RBPs has been reported to co-
purify with any known RNA binding proteins; contamination
with co-purifying proteins is therefore unlikely to account for these
results.
While our overall validation rate was 34%, proteins with greater
signal intensity/background in the protein microarray experiment
were significantly more likely to be validated by our IP microarray
experiments (Kolmogorov-Smirnov test p-value=0.03). Six of the
eight proteinstestedthat ranked amongthetop 50insignalintensity
in the protein microarray experiments co-purified with specific sets
of RNAs. 26 additional proteins that ranked in the top 50 are not
currently annotated as RBPs; these represent good candidates for
investigation by IP microarray experiments (Table S6).
Novel RBPs are functionally diverse and lack recognizable
RNA-binding domains
Mirroring the variety of functional classes that were initially
included in the IP experiments, the proteins that we found
associated with RNA in vivo carry out diverse functions and localize
to different sub-cellular compartments (Table 2). Lys1 and Gis2
are the only proteins that contain domains known to bind to
nucleic acid. Lys1 contains an NAD(P)-binding Rossman fold
domain motif similar to the one reported to have RNA-binding
activity in GAPDH [10], and Gis2 is a zinc-finger domain
containing protein (independently identified as an RBP by another
group (Scherrer and Gerber, submitted). The remaining RNA-
binding proteins newly identified in this study do not have
domains known to bind nucleic acids.
One interesting example of a novel RBP lacking a known RNA
binding domain is Crg1- a putative S-adenosyl-methionine
methyltransferase, whose targets are enriched for mRNAs
encoding proteins important for cellular developmental processes
like the maintenance of chromosome integrity (Table S5 and
Figure 3). The substrates methylated by diverse SAM methyl-
transferases include DNA, rRNA, proteins and small molecules
and many methyltransferases are involved in transcriptional
control ([29] and others) and receptor-mediated signaling [30].
In addition, histone methyltransferases have been found in a
complex with proteins and mRNAs [31]. However, to the best of
our knowledge, Crg1 is the first example of an S-adenosyl-
methionine methyltransferase that associates with mRNA. One
possibility is that Crg1 may methylate its target mRNAs,
potentially as a means of regulating their translation or stability.
Alternatively, the methyltransferase target RNAs could guide the
enzyme to specific loci, a model recently proposed by Khalil et al.
for mammalian lincRNAs and chromatin-modifying components
[32]. Another possibility in light of recent reports [31] is that Crg1
and its target mRNAs are recruited to the same site to facilitate
localized translation and protein complex assembly.
Other novel RBPs appear to play dual roles as metabolic
enzymes and RNA-binding proteins; Lys1, Gcy1, and Pcs60
encode enzymes that participate in lysine biosynthesis, glycerol
and fatty-acid metabolism, respectively. Pcs60 co-purified with
mRNAs encoding proteins involved in triglyceride metabolism
(hypergeometric p-value=8.5610
23) (Table S5 and Figure 3).
Lys1 interacted with .1,000 mRNAs, of which the most highly
enriched include a remarkably high fraction intrinsic membrane
Table 2. Novel RBPs identified in the protein microarray experiments and confirmed by IP-microarray experiments.
Name Function/Description Number of Targets (at FDR#0.01) Cellular Component
Scd6 RNA processing 1711 Cytoplasm
Gus1 t-RNA synthetase 12 Cytoplasm, mitochondrion
Arc15 Motility of actin patches 171 Actin patch, mitochondrial outer membrane
Arf3 Ras-GTPase; patch localization 855 Bud neck, bud tip
Arp8 Actin-related; chromatin remodeling 231 Nucleus
Crg1 Putative SAM-dependent methyltransferase 419 Unknown
Gcy1 NADP+- dehydrogenase; glycerol catabolism 44 Cytoplasm, nucleus
Gis2 Zn-finger; Ras signaling 151 Cytoplasm
Hsp26 Chaperone; heat shock response 279 Nucleus, cytoplasm
Lys1 NAD+- dehydrogenase; lysine biosynthesis 1353 Cytoplasm
Mtq2 SAM-dependent methyltransferase 111 * Cytoplasm, nucleus
Pad1 Decarboxylase 86 Mitochondrion
Pcs60 AMP-binding synthetase; fatty acid metabolism 969 Cytoplasm, peroxisomal membrane/matrix
Smy1 Exocytosis; kinesin 152 * Mating projection tip
Ubp3 Protease; ER-to-Golgi transport 1110 Cytoplasm
Vtc1 Chaperone; trafficking 243 ER, vacuolar membrane
For each of these RBPs, three replicate IP-microarray experiments were performed. In bold, are shown predicted and known RBPs that were used as positive controls.
Number of targets with FDR#0.01% (determined using SAM) is shown for each protein. Smy1 and Mtq2 (*) is an exception- it has no targets at FDR#0.01% and we used
FDR#1% as a cut-off. Protein localization data from [8].
doi:10.1371/journal.pone.0012671.t002
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27), particularly amino
acid transporters (hypergeometric p-value=1.0610
22) (Figure 3).
Arc15-a component of the Arp2/3 complex-co-purified with the
LAS17 mRNA, which encodes the assembly factor of the Arp2/3
complex, as well as 10 other mRNAs encoding components of the
actin patch organization (Table S5 and Figure 3). It is possible
therefore that the co-localization of these mRNAs could subse-
quently direct their localized translation and promote the forma-
tion of the Arp2/3 protein complex and the assembly of the actin
patch.
Figure 3. GO Term enrichment of targets for novel RBPs identified by IP-microarrays. Enrichment was determined using GO Term search
by [43] on target genes with FDR#0.01% (with the exception of Smy1 and Mtq2, which are not counted as RBPs, for which targets with FDR#1%
were considered). Hypergeometric p-value,0.05 (corrected for multiple hypothesis testing) was used as a cut-off. Complete target datasets are
available in Table S5. In blue, are shown enriched ‘‘Biological Process’’ and in red- ‘‘Cellular Component’’.
doi:10.1371/journal.pone.0012671.g003
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preferentially associated with transcripts encoding ER, membrane,
and vacuolar components (Figure 3). Ubp3 had .1,000 targets at
an FDR threshold of #0.01%. Among the Ubp3 targets, we
observed enrichment of mRNAs encoding protein components of
the cell cortex (Kolmogorov-Smirnov test p-value=2.5610
23),




Since Ubp3 physically interacts with the known RBP, Bre5, it is
possible that the apparent RNA-binding activity of Ubp3 is
attributable to Bre5. Our mass spectrometry results identified an
7 additional vesicle and membrane trafficking proteins (components
of both COPI and COPII- Table S2) that could also represent bona
fide RBPs, though we have yet to confirm them independently. The
significant enrichment of mRNAs encoding proteins found in
specific sub-cellular compartments among the targets of the
transport/trafficking proteins Vtc1 and Ubp3 suggests that proteins
with distinct roles in trafficking membranes may also participate in
the transport and localization of mRNAs to specific sub-cellular
locations.
The two positive control RBPs, Scd6 and Gus1, immunopur-
ified with RNA as expected (Table S5 and Figure 3). Interestingly,
the RNAs most enriched in association with Gus1 were MES1 and
ARC1, encoding two proteins with which Gus1 forms a complex in
vivo [35]. It was therefore plausible that the association between
Gus1 and the ARC1/MES1 mRNAs might be mediated by co-
translational assembly of a complex of the three proteins [31]. We
tested this hypothesis by isolating Gus1 in the presence of EDTA
to disassemble ribosomal subunits and disrupt any linkage between
a nascent polypeptide and its cognate mRNA. EDTA did not
disturb the association between the Gus1 protein and the ARC1-
MES1 mRNAs (data not shown). These results are consistent with
a scenario in which ARC1 and MES1 are co-localized independent
of translation by direct interaction with Gus1—potentially as a
means of coordinating the translation and subsequent assembly of
the Gus1-Arc1-Mes1 protein complex.
In summary, our follow-up IP-microarray experiments revealed
RBPs among several unexpected classes of proteins, most with
known ’’day jobs’’ as enzymes in metabolic and other processes. In
addition, we found evidence for the coordinated regulation of
mRNAs encoding subunits of protein complexes and a possible
link between mRNA trafficking and vesicle transport. Our results
add to the growing number of enzymes that appear to bind specific
RNAs and may have roles in post-transcriptional regulation
([10,36,37,38] and others), despite the lack of conventional RNA-
binding domains. Their unexpected identification by this empirical
approach highlights the value of reliable, scalable experimental
methods to look for novel RBPs.
Summary
Accumulating evidence points to a vast network of RNA-protein
interactions in yeast, mammals and other eukaryotes, but the
features and molecular components of this network are still largely
unexplored. Much of what is known about the ,600 annotated
RNA binding proteins in Saccharomyces cerevisiae suggests that there
are more RBPs to be identified, many among unexpected classes
of proteins lacking known RNA binding domains. In light of the
limitations of current bioinformatic methods that rely upon
homology to known RNA binding domains, there is a clear need
for systematic scalable experimental methods for the discovery of
novel RBPs.
We developed two experimental approaches to search for novel
RNA-protein interactions. One method combines affinity purifi-
cation with mass spectrometry to identify proteins from a whole
cell lysate that co-purify with total mRNA. This method yielded
interesting novel RBPs (Table S2), but is subject to the limitations
of conventional mass spectrometry. It identified only a relatively
small number of proteins, significantly biased towards highly
abundant proteins. Consequently, we developed a more robust
approach that uses protein microarrays and overcomes the
limitations of mass spectrometry. We designed microarrays that
represent .80% of the yeast proteome, enabling a nearly genome-
wide interrogation of RNA-protein interactions in vitro. While we
focused here on how this method can be used to search for novel
RNA binding proteins, the protein microarray platform has other
potential applications, including discovery of novel RNA-protein
interactions for an individual RNA or a defined pool of RNAs. As
an illustration, we successfully employed the protein microarrays
to look for proteins that interact specifically with the ASH1 mRNA.
Protein microarrays could also be used to detect selective RNA-
protein interactions with modified (methylated, etc.) or partially
processed (spliced, capped, etc.) mRNAs.
Our systematic search for novel RBPs yielded several
unexpected findings. Data from the MS and protein microarray
approaches confirmed that there are still many more RBPs than
have been recognized to date. In follow-up experiments, 12 of 35
selected candidate novel RBPs with a range of ranks in the protein
microarray data co-purified with specific sets of mRNAs with
shared functional themes. A majority of the 12 novel RNA-
binding proteins were enzymes, adding to growing evidence that
enzymes can have important RNA-binding roles ([10,39] and
others). With the exception of Gis2 and Lys1, the novel RBPs
described in this work have no known RNA binding domains,
suggesting the possibility that the evolution of these RNA-protein
interactions involved selection for RNA aptamer-like elements in
the mRNAs, capable of binding selectively to a protein; i.e. the
RNAs evolved protein-specific domains and not vice versa. In
support of this hypothesis, aconitase, originally annotated as an
enzyme with a central role in energy production, was later
discovered to play a role in post-transcriptional regulation of iron
metabolism through interaction with an RNA stem-loop aptamer
[40,41]. Recent work has shown that a conformational switch to
form a tRNA aptamer is at the heart of the mitochondrial import
of specific tRNAs by enolase-preMSK1 [11]. Additional experi-
ments will be required to define the structural basis of the RNA-
protein interactions and their evolutionary origins, and to
determine exactly how the fate of target mRNAs is affected by
the novel RBPs.
Following the law of parsimony, individual proteins are
generally assumed to have a single function. There is increasing
evidence, however, that many proteins have more than one
important role; RNA-binding may be a particularly common
‘‘moonlighting’’ role. Searching for RNA-binding activity in
unlikely places requires an efficient, scalable experimental
approach. The two genome-wide experimental methods presented
here may help to shed light on the largely unexplored landscape of
post-transcriptional regulation. Our results suggest that the cell’s
network of RNA-protein interactions is larger and richer than
expected. An analogous study should enable unexpected RBPs to
be discovered in humans and other organisms of interest.
Materials and Methods
Purification of GST-tagged ORFs
Glycerol stocks were streaked on SC-Ura plates (6.7 g Difco
Yeast Nitrogen Base without Amino Acids (Difco Cat# 291940),
2 g SC-Ura (Sunrise Scientific Cat# 1306–030), 20% glucose,
20 g agar) and colonies were inoculated in SC-Ura liquid medium
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Ura, 20% glucose). The liquid cultures were allowed to grow
overnight, then 100 uL of each were diluted in 2 mL of SC-Ura
media with 2% raffinose (6.7 g Difco Yeast Nitrogen Base without
Amino Acids, 2 g SC-Ura, 20% raffinose) and cultures were
grown to OD600 ,1.0. Then, expression of the protein was
induced by the addition of 200 uL of 20% galactose (to a final
concentration of 4%) followed by growth for 6 hours with shaking.
Half of each culture was added to a 96-well plate and pelleted by
centrifugation at 3,000rpm for 3 minutes at 4uC. The remaining
half of each culture was added and the centrifugation step was
repeated. Then, 250 uL of acid-washed glass beads were added to
each well and the cells were frozen at 280uC.
On the day of lysis, 50 uL of Tris Lysis I Buffer (50 mM Tris-
HCl pH 8.0; 150 mM NaCl; 5 mM EDTA; 5% glycerol; Roche
protease inhibitor complete; 1 mM PMSF; 0.5 mM DTT) and
cells were lysed in a Harbil paint shaker (Fluid Menagement) for 3
cycles of 2 minutes each, placing the plates on ice for 2 minutes in
between cycles. Then, the plates were centrifuged 3,000rpm for 1
minute at 4uC and 600 uL of Tris Lysis II Buffer (50 mM Tris-
HCl pH 8.0; 150 mM NaCl; 0.5 mM EDTA; 5% glycerol; 1%
Triton X-100; 1 mM PMSF; 0.5 mM DTT) was added to each
well. Cells were lysed 2 additional times for 2 minutes each in the
paint shaker and centrifuged at 3,000rpm for 10 minutes at 4uC.
In the meantime, glutathione-sepharose 4B beads (Amersham
Cat#17-0756-01) were washed with 1 bed volume of Tris Lysis II
Buffer 3 times, spinning at 3,000rpm for 1 minute at 4C to collect
beads between washes. Beads were resuspended in Tris Lysis II
Buffer to yield 50% slurry. 600ul of the spun-down lysate were
transferred to a clean 1.2 ml 96-well plate and 75ul of equilibrated
50% glutathione-sepharose were added to each well. Plates were
incubated at 4uC for 2 hours with shaking (200rpm), inverting
manually 1–2 times during the 2-hour interval to ensure mixing.
Then, the plates were spun down at 3,000rpm for 2 minutes at
4uC and the supernatant was discarded. The bead slurry was
transferred to a 1.2 micron 96-well PVDF filter-plate (Millipore)
sealed over a polypropylene receiving plate and spun at 3,000rpm
for 1 minute at 4uC. The filtrate was discarded and the beads were
washed three times with 200 uL Hepes Wash Buffer (50 mM
Hepes pH 7.5; 300 mM NaCl; 5% glycerol; 0.1% Triton X-100;
0.1 mM PMSF; 0.5 mM DTT) each; centrifuging 3,000rpm for 1
minute at 4uC in between washes. 50 uL of Elution Buffer (50 mM
Hepes pH 7.5; 200 mM NaCl; 25% glycerol; 0.08% Triton X-
100; 0.5 mM DTT; 20 mM reduced glutathione; sodium
hydroxide to a pH of 7.5–8.0) were added to each well and the
PVDF/receiving plates were sealed and incubated at 4uC
overnight. On the next morning, the plates were centrifuged
3,000rpm for 10 minutes at 4uC, the PVDF filter plate was
discarded and the receiving plate (containing the eluted protein)
was sealed and frozen at 280uC.
Protein microarray design
We purified .4,700 proteins from the yeast GST-tagged
collection (Open Biosystems Cat# YSC4423). Arrays were printed
on modified nitrocellulose coated glass PATH slides (GenTel
Biosciences Cat# 2-1025) with a 48-pin contact printer (Bio-Rad
ChipWriter Pro). The surface of these PATH slides is optimized
for printing protein microarrays and designed for applications that
require fluorescent detection [42]. We also included spots
containing elution buffer only for the purpose of ruling out
background fluorescent signal due to the composition of the
elution buffer alone. Also, Cy3-anti-biotin antibody spots were also
printed in each corner and used for proper alignment of the
blocks.
In order to estimate amount of GST-protein per spot, we
probed arrays with monoclonal anti-GST conjugated to Hilyte
Fluor 647 (Abcam Cat# ab64370) at 1:50 dilution. Arrays were
blocked, probed and processed as described in the section below.
Proteins were ranked based on mean Cy5 of a spot divided by
normalized Cy5 background signal as a proxy for amount of
protein present in each spot. No correlation was found between
this ranking and the ranking of proteins based on affinity for total
mRNA (data not shown).
Protein Microarray sample preparation and hybridization
Total RNA was extracted from mid-log yeast grown in YPD
media using PureLink Micro-to-Midi Kit (Invitrogen Cat# 12183-
018). PolyA-RNA was selected and amplified with Ambion’s
Aminoallyl MessageAmp II aRNA Kit (Ambion Cat# AM1753)
to make antisense-RNA, which was tailed and used for a second
round of selection and amplification with the kit to make mRNA.
The mRNA concentration was determined using a Nanodrop.
ASH1 was PCR-amplified using the following primer pair: forward
59-CGAGCTCATGTCAAGCTTATACATCA-39 and reverse 59-
CGATATCTCAATTCTCTACTGTCT-39. The DNA product
was digested with SacI and EcoRV and cloned into a pBluescriptII
KS+ phagemid (Stratagene Cat# 212207) and the sequence of the
DNA was confirmed by Sanger sequencing prior to in vitro
transcription. The ASH1 RNA yield was quantified with a Nanodrop
and size was verified by running on a denaturing gel.
Prior to microarray hybridization, each microarray was allowed
to equilibrate at 4C for at least 15 min and then pre-blocked in
25–30 mL Blocking Buffer (1X PBS; 1% BSA w/v; 1 mM DTT;
50 mg/mL E.coli tRNA; 20 mg/mL heparin) at 4uC for 2 hours
with gentle shaking. For the RBP discovery experiments, 10 mgo f
poly(A)-selected mRNA and 60 picomoles of specific in vitro
transcribed control RNA were labeled with Cy5 and Cy3-dye
NHS-monoesters (GE Healthcare Life Sciences Cat# RPN5661)
respectively. For the ASH1 experiments, 60 picomoles of in vitro
transcribed ASH1 mRNA and 10 mg of total mRNA were labeled
with Cy5 and Cy3, respectively. For dye-swap experiments, dyes
were reversed. Excess dye was removed using Ambion’s
AminoAllyl MessageAmp II aRNA Kit (Ambion Cat#
AM1753) by pooling the Cy5 and Cy3 labeled samples before
loading on the clean-up columns. The labeled pool was eluted
twice in 20 ul of preheated water each and dye incorporation was
quantified using a Nanodrop.
A total of 30 uL of eluted RNA sample was mixed with 30 uL of
2X Sample Buffer (40 mM Tris-HCl pH 8.0; 150 mM NaCl;
4 mM MgCl2; 10% glycerol; 0.1% Triton X-100; 2% BSA w/v;
2 mM DTT; 40 mg/mL heparin; 0.4 mg/mL E.coli tRNA) and
0.2 uL of Superase-IN and pipetted on a protein chip. The
microarray was incubated for 90 minutes at RT in the dark. Each
slide was washed twice for 10 minutes at 4uC each with ,25 mL
cold 1X Sample Buffer (with 5 U/mL Superase-IN) and twice for
10 minutes at 4uC each with ,25 mL cold 1X Sample Buffer
(with 5 U/mL Superase-IN) without E.coli tRNA. The microarray
was dried in an ozone-free centrifuge by spinning at 300rpm for 4
minutes at room temperature and scanned using either Axon-
scanner 4000A or 4000B (Molecular Devices). The intensity of
each protein spot was analyzed with the GenePix Pro 6.0 software
(Molecular Devices). Microarray data were uploaded on the
Stanford Microarray Database (http://smd.stanford.edu/cgi-bin/
login.pl) and are available for download. Proteins were ranked
based on mean-normalized channel intensity/normalized back-
ground. For identifying specific ASH1-interactors, mean-normal-
ized Log2(ASH1-Cy dye)/(total mRNA-Cy dye) ratios were
calculated. Enriched GO Terms were identified using SGD’s
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goTermFinder.pl). To calculate the RBP enrichment threshold,
we created a sliding window plot (window size of 200) to plot the
fraction of annotated RBPs vs. the protein microarray signal-to-
background (Figure S4). We then found the RBP enrichment
threshold as the point at which this line first equals the average
frequency of annotated RBPs in the entire data set (0.11), which is
at a signal-to-background value of 1.65 (and a relative rank of
,480). This threshold was later used to calculate the significance
of the relationship between protein microarray rank and the
candidate novel RBP validation rate.
mRNA Pulldown-LC-MS/MS Assay
For the mRNA pulldown experiments, we used BcMagHmRNA
oligo(dT) beads from Bioclone (Cat# MMS-106) with binding
capacity 1 ml beads per 2mgs total RNA. Beads were equilibrated
in Binding Buffer (100 mM Hepes pH 7.5; 500 mM LiCl; 10 mM
EDTA; 10 mM DTT; Superase-IN). We compared the efficiency
of capture of a known RBP when oligo(dT) beads were
preincubated with total RNA isolated from exponentially growing
yeast prior to addition of whole cell lysate (run #1) to that when
oligo(dT) beads were directly incubated with the lysate (run #2).
There was no apparent difference between the two approaches in
the amount of one specific RBP (Ypl184c) that was recovered in
each case monitored on a Western blot (data not shown). In run
#1, we preincubated beads with 2mgs of total yeast RNA, isolated
with Purelink Micro-to-Midi kit (Invitrogen Cat#12183-018) from
mid-log phase cells in YPD, for 10 minutes at room temperature
on a rotator and then added whole cell lysate (also from mid-log
phase cells) and incubated for another 10 minutes at room
temperature on a rotator. In run #2, we added yeast lysate from
cells in mid-log phase in YPD directly to the beads and incubated
for 10 minutes at room temperature on a rotator. After incubation
with lysate, the beads were washed 4 times each in four volumes of
Washing Buffer (10 mM HEPES pH 7.5; 150 mM LiCl; 1 mM
EDTA) and RNA-protein complexes were eluted by heating at
65uC for 3 minutes in 1 mL of Elution Buffer (10 mM Hepes
pH 7.5). Eluate was concentrated and submitted for in-solution
tryptic digest and LC-MS/MS analysis at the Stanford University
Mass Spectometry Facility (http://mass-spec.stanford.edu/). Data
were analyzed using Scaffold Proteome Software (http://www.
proteomesoftware.com/proteome_software_scaffold_sample_data.
html). Enriched functional categories were identified using SMD’s
GO Term Finder and hypergeometric p-values were corrected for
multiple hypothesis testing [43].
Purification of Candidate RNA-Binding Proteins and
Associated RNAs
Candidate RNA-Binding Proteins (RBPs) were affinity purified
and their associated RNAs were identified by microarray analysis,
essentially as previously described [5]. A total of 35 candidate
RBPs (Table S4) were selected for validation based on their
relative rank in the protein microarray data (ranked by signal/
background) alone. The protein microarray ranks of the candidate
RBPs that were selected for validation varied widely, from 3 to
3,746. Initially, 1–2 replicate affinity purifications were performed
for each candidate RBP. TAP-tagged yeast strains derived from
BY4741 (Open Biosystems Cat# YSC1177) were grown to an
OD600 of 0.6–0.8 in minimal media (6.7 g Difco Yeast Nitrogen
Base without amino acids, 60 mg L-Leucine, 20 mg L-Histidine,
20 mg L-Methionine, 20 mg Uracil, and 20 g glucose per liter) or
YPD [1]. For each IP, cells from mid-log phase cells were
harvested by centrifugation, washed twice with buffer A (50 mM
HEPES pH 8.0, 140 mM KCl, 1.8 mM MgCl2, 0.1% NP-40, and
0.2 mg/mL heparin), resuspended in buffer B (buffer A with 1ug/
mL Pepstatin, Leupeptin, and Vanadate, 2.5ug/mL Aprotinin,
1 mM PMSF, 0.5 mM DTT, and 0.1U/uL Superasin Rnase
inhibitor from Ambion), and lysed by Mini bead-beater 8 from
Biospec products (Cat# 693) with four 1-min cycles at max speed.
Lysate was cleared by centrifugation for 10 minutes at 8,000xg and
4uC, and total protein concentration was adjusted to ,15 mg/mL
by dilution with buffer B. Biotinylated rabbit IgG was coupled to
streptavidin coated magnetic beads (Invitrogen Cat# 602-10).
Beads were incubated with lysate for 2 hours, then washed for 15
minutes on rotator at 4uC, once with buffer B and three times with
buffer C (buffer B with 10% Glycerol and no heparin or vanadate).
100uL of the lysate remaining after the beads were removed was
set aside for the isolation of reference RNA. IP RNA was isolated
with phenol:chloroform as described elsewhere [5]. Total RNA for
use as a reference was purified from the lysate remaining after the
2 hour incubation with the beads, using PureLink Micro-to-Midi
Kit (Invitrogen Cat# 12183-018).
For the initial round of IPs, a total of four separate negative
control purifications (‘‘Mocks’’) done with lysate from untagged
BY4741 strains were performed on cells grown in either minimal
media or YPD (two with each media type). Candidate RBPs from
cells grown under different media conditions were purified
separately, and the microarray data was analyzed separately.
Proteins that co-IPed with RNAs very different than the Mocks
were grown in minimal media and re-purified in duplicate as
described above. For the second round of experiments, a total of 6
mock IPs were performed. This yielded a total of 2–3 replicates for
the most promising candidate RBPs, and 8 mock IP replicates.
DNA Microarray Production and Pre-hybridization
Processing
Yeast DNA microarrays were printed on epoxysilane-coated
glass (Schott Nexterion E) by the Stanford Functional Genomic
Facility. The DNA oligonucleotide printed were previously
described [5]. Further information about the probes used,
including probe sequences, is available from the Operon Web
site (https://www.operon.com/; S. cerevisiae YBOX V1.0).
Detailed protocols for microarray experiments can be found
on the Brown lab website (http://cmgm.stanford.edu/pbrown/
protocols/index.html). The microarray prehybridization per-
formed has been previously described [44]. Within 24 hours prior
to hybridization, slides were placed in a humidity chamber (Sigma
Cat# H6644) filled with 100 mL of 0.56 SSC (16 SSC=
150 mM NaCl, 15 mM sodium citrate [pH 7.0]) for 30 minutes at
room temperature. Slides were then dried rapidly at 70–80uCo na
heat block. The epoxysilane surface of the slides was blocked by
incubation with 1M Tris-HCl (pH 9.0), 100 mM ethanolamine,
and 0.1% SDS for 20 min at 50uC. After blocking, the slides were
washed twice for 1 min with 400 ml of water, and then dried by
centrifugation.
DNA Microarray Sample Preparation, Hybridization, and
Washing
PolyA-RNA was selected, amplified, purified, and labeled with
Cy-dyes using Ambion’s Aminoallyl MessageAmp II-96 aRNA Kit
(Ambion Cat# AM1819). Up to 5 mg of RNA was used as input
for each RT reaction. In-vitro transcribed RNA was then coupled
to NHS-monoesters of either Cy5-dye for RNA that co-purified
with the candidate RBP, or Cy3-dye for the reference RNA (GE
Healthcare Life Sciences Cat# RPN5661).
Up to 10ug of Cy5-labeled samples were pooled with 10ug of
their appropriate Cy3-labeled counterparts, and combined with
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Hepes-NaOH (pH 7.0), 20 mg of poly(A) RNA (Sigma Cat#
P9403), and 0.3% SDS) to yield a total volume of 50uL. Samples
were then heated to 70uC for 5 minutes, spun at 14,000 rpm at
room temperature in a microfuge for 10 minutes, then hybridized
at 65uC using the MAUI hybridization system (BioMicro) for 12–
16 h.
After hybridization, slides were washed first in a solution of 2x
SSC with 0.05% SDS at 70uC for 5 minutes, then in 2x SSC at
room temperature for 2 minutes, then in 1x SSC at room
temperature for 2 minutes, then 0.2x SSC at room temperature for
2 minutes. Slides were then dried dried by centrifugation in a low-
ozone room (,5ppb).
DNA Microarray Scanning and Data Processing
Microarrays were scanned using AxonScanner 4000B (Molec-
ular Devices). PMTs were adjusted to maximize signal, without
excessive background and pixel saturation. Microarray spots were
located and their data extracted using the GenePix Pro 6.0
software (Molecular Devices). All data is MIAME compliant and
the raw data has been deposited in a MIAME compliant database.
The microarray data have been submitted to Stanford Microarray
Database (http://smd.stanford.edu/cgi-bin/login.pl) and Gene
Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo/) under
the accession number GSE22876. The data was filtered for signal
vs. background using several parameters. Specifically, the Cy5
(red) vs Cy3 (green) pixel intensity values for each spot must have a
correlation coefficient (R-squared) .0.6. In addition, the signal
intensity minus the local background for each spot must be greater
than 100, or greater than 3x the standard deviation of the local
background (surrounding each spot). Signal in either channel that
failed these filtering criteria was considered absent. Spots with
green signal but no red signal were kept separated as RNAs that
were expressed but did not co-purify with the candidate RBP.
Finally, both the technical replicates of each DNA oligonucleotide
(each oligonucleotide was printed twice per microarray) had to
pass filtering for that spot to be considered as a possible target of a
given candidate RBP. The log (base 2) of the Cy5 to Cy3 ratio
(Log2 Ratio or L2R) for each spot that passed filtering was used for
the subsequent analyses.
Analysis of DNA Microarray Data—Part A
The single IP data from our initial list of 35 candidate RBPs
were analyzed to determine if a given candidate RBP was co-
purifying with a set of RNAs that was significantly different from
the RNAs that co-purify with the mock un-tagged control
experiments. The purpose of this analysis was to select the most
promising candidate RBPs for additional replicate purifications.
The method we used is based on the observation that microarray
analysis of RNAs enriched in replicate assays of known RBPs or
replicates of negative controls (Mocks), respectively, each have
high Spearman correlation coefficients between the resulting
enrichment ratios, but when enrichment results for a known RBP
are compared to those for a Mock experiment, the correlation
coefficient tends to be much smaller. The Spearman correlation
coefficient between a known RBP and a Mock tends to decrease as
the number of targets of that RBP increased.
First, Spearman rank correlation coefficients were calculated on
the intersection of the Log2 Ratio data from a given candidate
RBP and the average of the Mock replicates. To create a null
distribution for the rank correlation coefficient, replicate spots
from two Mock microarrays were treated as a separate microarray
by enumerating replicate spots 1, 2, 3, or 4 arbitrarily and
assigning all spots with ‘‘i’’ to the ith array, resulting in 4 Mock
arrays. These Mocks were then permuted by randomizing the
microarray names on a gene by gene basis (240,000 possible
permuted mock arrays). Then, Spearman rank correlation
coefficients were calculated for 60,000 pairwise comparisons
between permuted Mocks. These correlation coefficients were to
compute an empirical p-value for testing for significantly
decreased correlation against the average Mock at a level of
p,0.005. Fifteen of the 35 candidate RBPs were significant at this
level (without correction for multiple hypothesis testing). For more
rigorous validation and testing they were tested again by the IP
microarray assay in duplicate, providing 2 additional replicates of
each.
Analysis of DNA Microarray Data—Part B
To identify the specific RNAs that were associated with each
candidate RBP, the Log2 ratios from each microarray were
normalized to the average of the Mock arrays (the average of the
Mock arrays was calculated after median normalization). To do
this, we used an algorithm (Salzman and Klass, in preparation).
Briefly, the algorithm selects a set of genes (here we used a set size
of 450) that have the greatest difference in relative rank (ranked by
Log2 ratio) between the Mock and the candidate RBP microarray.
These genes are enriched in the Mock, suggesting they are
prominently composed of background signal, but they are not
enriched in the RBP IP, suggesting they are not strong RBP
targets. Therefore, this set of genes is presumed to model true
background in both the Mock and RBP IP. Each distribution is
normalized so that the mean of the set of selected background
genes is the same in each IP and the average Mock. As the
distributions have been normalized relative to each other, the
contribution of background binding (represented by the Mock) to
the Log2 ratio values for an RBP can simply be subtracted on a
gene-by-gene basis, yielding Mock corrected Log2 ratios for each
gene. Genes with Mock corrected Log2 ratios greater than zero
theoretically represent genes that were more enriched in the RBP
IP than in the Mock IP, however, by its nature the procedure can
produce some false enrichment.
Every microarray in the experiment was processed as described
above, including the Mock arrays. Each Mock microarray was
normalized relative to the average of all the other Mock arrays,
and the average of all the other Mock arrays was then subtracted
from it. This resulted in Mock corrected Log2 ratio values for
every microarray, including the Mock arrays.
The Mock corrected Log2 ratios for each microarray were then
used as input to the Significance Analysis of Microarrays (SAM)
algorithm [26]. 100,000 permutations of 2-class SAM analysis
were performed comparing all replicates of each RBP to all
replicates of the Mock. We took as targets any mRNAs that had a
SAM-calculated False Discovery Rate (FDR) less than or equal to
0.01%, and in the case of proteins with many mRNA targets
(greater than 500) we also required a Mock Corrected L2R value
greater than 1 (Table S5). We called proteins with mRNA targets
that met these criteria bona fide RBPs. Gene Ontology (GO) term
enrichment for the mRNAs associated with each candidate RBP
was calculated comparing these mRNA targets to all the genes that
had green signal above background on the microarray using the
hypergeometric test (Figure 3), correcting for multiple hypothesis
testing [43]. To test whether there was a significant relationship
between the protein microarray rank and the probability of
validation by IP microarray, we used the KS-test on all proteins we
had purified with ranks above the RBP enrichment threshold (at a
protein microarray rank of ,480, see Figure S4).
To test the false positive rate of our analysis method, pairs of
Mock IPs were removed at random from the set of Mock
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analysis script as ‘‘fake’’ candidate RBPs only. In this step, the pair
of Mock IPs being used as ‘‘fake’’ candidate RBPs was excluded





different pairs of Mock IPs, and never
produced a single mRNA target of these ‘‘fake’’ candidate RBPs
(at an FDR ,20%).
Supporting Information
Table S1 Annotated Saccharomyces cerevisiae RNA-Binding
Proteins. Data is compiled based on Gene Ontology information,
protein domain homology and gene descriptions from the
Saccharomyces Cerevisiae Database (http://www.yeastgenome.
org/).
Found at: doi:10.1371/journal.pone.0012671.s001 (0.19 MB
XLS)
Table S2 Proteins interacting with polyA-mRNA identified by
LC-MS/MS in two experiments. We removed proteins identified
by LC-MS/MS from whole cell lysate samples alone (‘‘Back-
ground’’). In ‘‘run1’’, oligo(dT) beads were preincubated with
purified total RNA prior to addition of whole cell lysate. In
‘‘run2’’, oligo(dT) beads were incubated directly with yeast lysate.
Protein abundance data are taken from [1]. Also shown is the rank
for each protein from protein microarray experiments with total
mRNA (data summarized in Table S3). Indicated by bold text are
annotated RBPs (data summarized in Table S1).
Found at: doi:10.1371/journal.pone.0012671.s002 (0.03 MB
XLS)
Table S3 Summary of protein microarray data. Proteins are
ranked according to the affinity for total yeast mRNA (as
measured by Cy5/normalized background). Data (‘‘Mean’’ signal)
are averaged for 3 replicate experiments.
Found at: doi:10.1371/journal.pone.0012671.s003 (1.18 MB
XLS)
Table S4 Proteins chosen for follow-up IP-microarray experi-
ments. These proteins have ranks ranging between 3 and 3746. In
bold, are shown proteins also identified by the polyA-mRNA IP-
LC-MS/MS experiment (refer to Table S2 for data).
Found at: doi:10.1371/journal.pone.0012671.s004 (0.03 MB
XLS)
Table S5 mRNA targets of novel RBPs identified in this study.
An FDR#0.01% was used as a cut-off for all proteins, except for
Smy1 and Mtq2. Smy1 and Mtq2 were not considered RBPs, but
targets are included for informational purposes.
Found at: doi:10.1371/journal.pone.0012671.s005 (1.92 MB
XLS)
Table S6 Potential novel RBPs based on protein array data.
Proteins with ranks 1–50 in protein microarray data that were not
included in follow-up IP-microarray experiments and could
represent novel RNA-binding proteins.
Found at: doi:10.1371/journal.pone.0012671.s006 (0.03 MB
XLS)
Figure S1 No bias based on protein size found in protein
microarray data. Data for protein weight from [1].
Found at: doi:10.1371/journal.pone.0012671.s007 (3.24 MB TIF)
Figure S2 No bias based on protein charge found in protein
microarray data. Data for protein weight from [2].
Found at: doi:10.1371/journal.pone.0012671.s008 (3.41 MB TIF)
Figure S3 No bias based on amount of protein per spot found in
protein microarray data. Amount of protein was estimated based
on signal intensity of Hilyte Fluor 647-conjugated anti-GST
antibody (1:50) the protein arrays were probed with.
Found at: doi:10.1371/journal.pone.0012671.s009 (3.40 MB TIF)
Figure S4 RBP Enrichment threshold for protein microarray
data. A sliding window plot of 200 proteins is used. The gray line
indicates the microarray signal-to-background value, at which the
average frequency of annotated RBPs for the entire microarray is
reached (=0.11), and the protein microarray data are not
significantly enriching for RBPs.
Found at: doi:10.1371/journal.pone.0012671.s010 (1.79 MB TIF)
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